Bristol-Myers Squibb Co (NYSE:BMY)

66.23
Delayed Data
As of 4:19pm ET
 -0.51 / -0.76%
Today’s Change
45.76
Today|||52-Week Range
68.34
+6.77%
Year-to-Date
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
Jan 19 / MotleyFool.com - Paid Partner Content
bluebird (BLUE) to Spin Off Oncology Unit Into Separate Entity
Jan 12 / Zacks.com - Paid Partner Content
Sana Biotech Market Cap Expected to Top $10 Billion Post-IPO
Jan 18 / GuruFocus News - Paid Partner Content
3 Recession-Proof Healthcare Stocks to Buy for 2021
Jan 12 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Gets EU Nod for Improved Imfinzi Dosing
Jan 18 / Zacks.com - Paid Partner Content
Bristol Myers Squibb Adds $2 Billion to Share Repurchase Program
Jan 11 / MotleyFool.com - Paid Partner Content
Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know
Jan 15 / Zacks.com - Paid Partner Content
bluebird bio to Spin Off Its Oncology Business
Jan 11 / MotleyFool.com - Paid Partner Content
BeiGene (BGNE) Up on Label Expansion of Tislelizumab in China
Jan 15 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Reports Preliminary Q4 Results, Business Updates
Jan 11 / Zacks.com - Paid Partner Content
Lexicon (LXRX) Soars on FDA Permission for Sotagliflozin NDA
Jan 15 / Zacks.com - Paid Partner Content
My Favorite Dirt-Cheap Dividend Stock Right Now
Jan 10 / MotleyFool.com - Paid Partner Content
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Jan 14 / MotleyFool.com - Paid Partner Content
3 Warren Buffett Stocks That Should Be Big Winners in 2021
Jan 10 / MotleyFool.com - Paid Partner Content
Bristol-Myers Freeing Up Cash for Additional Acquisitions
Jan 14 / GuruFocus News - Paid Partner Content
3 Top Biotech Picks for 2021
Jan 10 / MotleyFool.com - Paid Partner Content
Harpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag
Jan 14 / Zacks.com - Paid Partner Content
Infinity (INFI) Provides Data on Eganelisib in Urothelial Cancer
Jan 07 / Zacks.com - Paid Partner Content
3 Great Dividend Stocks That Are Simply Too Cheap to Ignore
Jan 14 / MotleyFool.com - Paid Partner Content
Xencor (XNCR) Inks Deal for Novel Antibody Therapies in Cancer
Jan 07 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
Jan 12 / Zacks.com - Paid Partner Content
Jeff Bezos, Jamie Dimon and Warren Buffett tried to solve health care. 3 years later, their company has shut down
Jan 04 / CNN.com - Paid Partner Content